On 2025-05-05, Oric Pharmaceuticals, Inc. (ORIC) announced earnings per share of $-0.42 for the fiscal quarter ending 2025-03-31, beating the average analyst estimate of $-0.51.
The next expected annoucement date for quarterly earnings is 2025-08-11, with an average estimated earnings per share of $-0.47 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-05-05 | 2025-03-31 | $-0.51 | $-0.42 |
| 2025-02-18 | 2024-12-31 | $-0.52 | $-0.51 |
| 2024-11-12 | 2024-09-30 | $-0.48 | $-0.49 |
| 2024-08-12 | 2024-06-30 | $-0.42 | $-0.45 |
| 2024-05-06 | 2024-03-31 | $-0.44 | $-0.37 |
| 2024-03-11 | 2023-12-31 | $-0.49 | $-0.49 |
| 2023-11-06 | 2023-09-30 | $-0.46 | $-0.44 |
| 2023-08-10 | 2023-06-30 | $-0.58 | $-0.50 |
| 2023-05-08 | 2023-03-31 | $-0.54 | $-0.53 |
| 2023-03-16 | 2022-12-31 | $-0.56 | $-0.52 |
| 2022-11-07 | 2022-09-30 | $-0.55 | $-0.63 |
| 2022-08-11 | 2022-06-30 | $-0.60 | $-0.51 |
| 2022-05-09 | 2022-03-31 | $-0.57 | $-0.59 |
| 2022-03-21 | 2021-12-31 | $-0.61 | $-0.58 |
| 2021-11-08 | 2021-09-30 | $-0.58 | $-0.47 |
| 2021-08-10 | 2021-06-30 | $-0.50 | $-0.57 |
| 2021-05-06 | 2021-03-31 | $-0.48 | $-0.45 |
| 2021-03-23 | 2020-12-31 | $-0.50 | $-0.84 |
| 2020-11-05 | 2020-09-30 | $-0.39 | $-0.84 |
| 2020-08-05 | 2020-06-30 | $-0.37 | $-0.51 |
| 2020-05-20 | 2020-03-31 | -- | $-4.46 |